Approval · Notice of Compliance 16731 · 2015
EGRIFTA: Notice of Compliance 16731
Issued March 27, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16731
- Date
- March 27, 2015
- Company
- Theratechnologies IncMontréal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength 1 mg/vial
- Therapeutic class
- Somatropin and somatropin agonists
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EGRIFTA | 02438712 | Cancelled Post Market |
Medicinal ingredients
- TESAMORELIN 1 MG per VIAL